Cytarabine and Dyslipidaemia - a phase IV clinical study of FDA data

Summary:

Dyslipidaemia is reported as a side effect among people who take Cytarabine (cytarabine), especially for people who are female, 30-39 old, also take Duphalac, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Dyslipidaemia when taking Cytarabine. It is created by eHealthMe based on reports of 65,319 people who have side effects when taking Cytarabine from the FDA, and is updated regularly.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.

What is Dyslipidaemia?

Dyslipidaemia (abnormal amount of lipids) is found to be associated with 842 drugs and 711 conditions by eHealthMe. Check the latest studies of Dyslipidaemia.

On Jul, 17, 2026

65,319 people reported to have side effects when taking Cytarabine.
Among them, 13 people (0.02%) have Dyslipidaemia.

Among these 13 people:

What is the gender of people who have Dyslipidaemia when taking Cytarabine? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Dyslipidaemia when taking Cytarabine? *

What are other drugs people take besides Cytarabine? *

Thioguanine: 7 people, 53.85%
Sulfamethoxazole: 7 people, 53.85%
Duphalac: 7 people, 53.85%
Sulfamethoxazole And Trimethoprim: 6 people, 46.15%
Pralatrexate: 3 people, 23.08%
Oncaspar: 3 people, 23.08%
Prednisolone: 1 person, 7.69%
Piperacillin And Tazobactam: 1 person, 7.69%
Mozobil: 1 person, 7.69%
Mitoxantrone: 1 person, 7.69%

What are other side effects people have besides Dyslipidaemia? *

Diabetes: 3 people, 23.08%
Amenorrhea (absence of a menstrual period in a woman of reproductive age): 3 people, 23.08%
High Blood Pressure: 2 people, 15.38%
Symptom Masked: 2 people, 15.38%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 7.69%
Acute Myocardial Infarction (acute heart attack): 1 person, 7.69%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 1 person, 7.69%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 1 person, 7.69%
Blood Sodium Decreased: 1 person, 7.69%
Cardiogenic Shock (inadequate circulation of blood): 1 person, 7.69%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 8 people, 61.54%
Constipation: 7 people, 53.85%
T-Cell Lymphoma (a blood cell cancer): 2 people, 15.38%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and have Dyslipidaemia?

- Check whether Dyslipidaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytarabine:

Cytarabine (65,358 reports)

Dyslipidaemia treatments and more:

Dyslipidaemia (42,009 reports)

Browse all side effects of Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyslipidaemia:

Dyslipidaemia (842 drugs)

Browse all the conditions that are associated with Dyslipidaemia:

Dyslipidaemia (711 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.